Drug intelligence / Profile preview

technetium-99m-labeled E48 F(ab')2

Development stage
Preclinical
Lead developer
Amsterdam UMC
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Gamma Emitters → Radiopharmaceuticals, Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Technetium-99m-labeled E48 F(ab')2 is an investigational **radioimmunoscintigraphy agent** comprising the F(ab')2 antigen-binding fragment of the murine monoclonal antibody E48 labeled with technetium-99m. It binds lymphocyte antigen 6 family member D, historically called the E48 antigen, a glycosylphosphatidylinositol-anchored surface protein expressed in stratified squamous and transitional epithelia and their corresponding tumors. The agent was administered intravenously for planar gamma-camera and SPECT imaging of primary tumors and cervical lymph-node metastases in head and neck squamous cell carcinoma. It was evaluated clinically as a diagnostic imaging tracer rather than as a therapeutic radiopharmaceutical.

Other names
99mTc-labeled E48 F(ab')299mTc-labeled monoclonal antibody E48 F(ab')2technetium-99m-labeled monoclonal antibody E48 F(ab')2
02

Targets

LY6D (Lymphocyte antigen 6 complex locus D)

Beyond the preview

Go deeper on technetium-99m-labeled E48 F(ab')2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium-99m-labeled E48 F(ab')2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call